Mitcham Inds Inc (MIND) 2.79 $MIND Mitcham Industries

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Mitcham Inds Inc (MIND) 2.79 $MIND

Mitcham Industries Announces Fiscal 2017 Second Quarter Earnings Release And Conference Call Schedule
PR Newswire - Wed Aug 10, 6:00AM CDT
Mitcham Industries, Inc. (NASDAQ: MIND) announced today that it will release financial results for its fiscal 2017 second quarter ended July 31, 2016 after the market closes on Wednesday, September 7, 2016. In conjunction with the release, the Company has scheduled a conference call, which will be broadcast live over the Internet, for Thursday, September 8 at 9:00 a.m. Eastern Time / 8:00 a.m. Central Time.
MIND: 2.79 (-0.02)

Mitcham Industries Reports Fiscal 2017 First Quarter Results
PR Newswire - Wed Jun 08, 3:15PM CDT
Mitcham Industries, Inc. (NASDAQ: MIND) ("the Company" today announced financial results for its fiscal 2017 first quarter ended April 30, 2016.
MIND: 2.79 (-0.02)

Mitcham Industries Announces Fiscal 2017 First Quarter Earnings Release And Conference Call Schedule
PR Newswire - Wed Jun 08, 6:45AM CDT
Mitcham Industries, Inc. (NASDAQ: MIND) announced today that it will release financial results for its fiscal 2017 first quarter ended April 30, 2016 after the market closes on Wednesday, June 8, 2016. In conjunction with the release, the Company has scheduled a conference call, which will be broadcast live over the Internet, for Thursday, June 9 at 9:00 a.m. Eastern Time / 8:00 a.m. Central Time.
MIND: 2.79 (-0.02)

Mitcham Industries Prices Public Offering of 9.00% Series A Cumulative Preferred Stock
PR Newswire - Thu Jun 02, 5:00PM CDT
Mitcham Industries, Inc. ("Mitcham" or the "Company" (Nasdaq: MIND) announced today that it has priced an underwritten public offering of 320,000 shares of 9.00% Series A Cumulative Preferred Stock ("Series A Preferred Stock" at a price of $25.00 per share, pursuant to a registration statement on Form S-1 previously filed with the U.S. Securities and Exchange Commission (the "SEC". In addition, Mitcham has granted the underwriter a 30-day option to purchase from it an additional 48,000 shares of Series A Preferred Stock. Dividends on the Series A Preferred Stock will be payable from and including the date of original issue at a rate of 9.00% per annum of the $25.00 per share liquidation preference (equivalent to $2.25 per annum per share). The offering is expected to close on or about June 8, 2016, subject to customary closing conditions
LTS: 2.29 (+0.01), MIND: 2.79 (-0.02)

Mitcham Industries Commences Public Offering of 9.00% Series A Cumulative Preferred Stock
PR Newswire - Wed May 18, 11:02AM CDT
Mitcham Industries, Inc. ("Mitcham" or the "Company" (Nasdaq: MIND) announced today that it has commenced an underwritten public offering of 600,000 shares of 9.00% Series A Cumulative Preferred Stock ("Series A Preferred Stock" at a price of $25.00 per share, pursuant to a registration statement on Form S-1 previously filed with the U.S. Securities and Exchange Commission (the "SEC". In addition, Mitcham expects to grant the underwriter a 30-day option to purchase from it an additional 90,000 shares of Series A Preferred Stock.
LTS: 2.29 (+0.01), MIND: 2.79 (-0.02)

Mitcham Industries Reports Fiscal 2016 Fourth Quarter And Full Year Results
PR Newswire - Tue Apr 05, 3:15PM CDT
Mitcham Industries, Inc. (NASDAQ: MIND) ("Mitcham" or the "Company" today announced financial results for its fiscal 2016 fourth quarter and full year ended January 31, 2016.
MIND: 2.79 (-0.02)

Mitcham Industries Announces Fiscal 2016 Fourth Quarter And Year-End Earnings Release And Conference Call Schedule
PR Newswire - Tue Apr 05, 6:00AM CDT
Mitcham Industries, Inc. (NASDAQ: MIND) announced today that it will release financial results for its fiscal 2016 fourth quarter and year-end ended January 31, 2016 after the market closes on Tuesday, April 5, 2016. In conjunction with the release, the Company has scheduled a conference call, which will be broadcast live over the Internet, for Wednesday, April 6 at 9:00 a.m. Eastern Time / 8:00 a.m. Central Time.
MIND: 2.79 (-0.02)

3 Sectors to Avoid as China Stock Market Takes a Bumpy Ride
Zacks Equity Research - Zacks Investment Research - Thu Jan 14, 3:53PM CST
This time not only did the Chinese investors suffer -- stakeholders all over the world felt the heat of this market slump.
ALNY: 69.85 (-0.90), BVN: 12.36 (-0.56), OCRX: 2.12 (-0.26), IPI: 1.38 (-0.02), MIND: 2.79 (-0.02), HELI: 3.67 (-0.33)

Mitcham Industries Acquires L-3 Communications Klein Associates
PR Newswire - Mon Jan 04, 3:15PM CST
Mitcham Industries, Inc. (NASDAQ: MIND) ("Mitcham" or "the Company" announced today that it has acquired L-3 Communications Klein Associates, Inc. ("Klein", a designer, manufacturer and worldwide distributor of sonar and waterside security systems to military and commercial customers. Klein was a wholly-owned subsidiary of L-3 Communications Corporation, a leading provider of a broad range of communication and electronic systems and products used on military and commercial platforms, and a prime contractor in aerospace systems.
MIND: 2.79 (-0.02)

Mitcham Industries Reports Fiscal 2016 Third Quarter Results
PR Newswire - Tue Dec 08, 3:15PM CST
Mitcham Industries, Inc. (NASDAQ: MIND) ("the Company" today announced financial results for its fiscal 2016 third quarter ended October 31, 2015.
MIND: 2.79 (-0.02)

Mitcham Industries Announces Fiscal 2016 Third Quarter Earnings Release And Conference Call Schedule
PR Newswire - Tue Dec 08, 6:45AM CST
Mitcham Industries, Inc. (NASDAQ: MIND) announced today that it will release financial results for its fiscal 2016 third quarter ended October 31, 2015 after the market closes on Tuesday, December 8, 2015. In conjunction with the release, the Company has scheduled a conference call, which will be broadcast live over the Internet, for Wednesday, December 9 at 9:00 a.m. Eastern Time / 8:00 a.m. Central Time.
MIND: 2.79 (-0.02)

/C O R R E C T I O N -- Mitcham Industries, Inc./
PR Newswire - Tue Nov 10, 10:00AM CST
In the news release, Mitcham Industries Announces Fiscal 2016 Third Quarter Earnings Release And Conference Call Schedule, issued 10-Nov-2015 by Mitcham Industries, Inc. over PR Newswire, we are advised by the company that the When section, should read "Wednesday, December 9, 2015 at 9:00 a.m. Eastern / 8:00 a.m. Central" rather than "Thursday, December 3, 2015 at 9:00 a.m. Eastern / 8:00 a.m. Central" as originally issued inadvertently. The complete, corrected release follows:
MIND: 2.79 (-0.02)

SCANA (SCG) Rate Hike Okayed for South Carolina Customers
Zacks Equity Research - Zacks Investment Research - Fri Sep 25, 3:10PM CDT
SCANA Corporation (SCG) announced that the Public Service Commission of South Carolina (SCPSC) has approved a $64.5 million rate hike.
BAK: 14.82 (+0.57), ALDW: 11.69 (unch), SCG: 70.65 (+0.50), MIND: 2.79 (-0.02)

Helix Energy Solutions (HLX) to Join S&P SmallCap 600 List
Zacks Equity Research - Zacks Investment Research - Fri Sep 25, 10:10AM CDT
Helix Energy Solutions Group, Inc. (HLX) announced that the company will make an entry into the S&P SmallCap 600 index after the market closes on Oct 1.
BAK: 14.82 (+0.57), HLX: 7.50 (-0.30), SPF: 8.00 (+0.05), MIND: 2.79 (-0.02)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Portillo's Faces Class Action: Investor Losses at Stake

Updated Category News Views 286

Investor Tensions Rise as Portillo's Inc. Lawsuit Unfolds Investment ain't all sunshine and rainbows, and if you've been holding Portillo's Inc. (NASDAQ: PTLO) stocks between September 19, 2023, and May 4, 2026, you might find yourself caught in a storm front. We're talking shareholder class action lawsuit, folks, thanks to some allegedly misguided management moves. This...

Continue Reading
Employment Law Suit Hits ABC: Alleged Wage Violations

Updated Category News Views 238

ABC Under Fire for Labor Code Violations You know it's a rocky road when a company like American Broadcasting Companies, Inc. lands itself in hot water with accusations riding high on labor law violations. People yapping about lunch breaks? Well, that’s the ball game here. Meal and Rest Break Controversies According to a recent lawsuit filed by Blumenthal Nordrehaug...

Continue Reading
D-Wave Quantum Hit with Securities Fraud Lawsuit

Updated Category News Views 380

A Legal Quagmire for D-Wave Quantum Investors Securities fraud lawsuits are like light in a dark alley—you need them when the truth's been stashed out of sight, but they illuminate the dirty and damp parts of investment strategies nobody wants to talk about. Right now, D-Wave Quantum Inc. is smack dab in the middle of such litigious action. If you had the misfortune of...

Continue Reading
IDEAYA's IDE101: A New Front in Cancer Battle

Updated Category News Views 305

IDEAYA's Bold Move in Precision Medicine IDEAYA Biosciences, no stranger to the frontlines of cancer treatment, is gunning for a breakthrough with their latest pick, IDE101. They're jumping into the ring with a potential first-in-class inhibitor targeting CDKN2A-deficiency—a notorious player in the solid tumor game. They're not just mixing things up for the sake of it;...

Continue Reading
Beef 'O' Brady's Expands Into Tuscaloosa Market

Updated Category News Views 310

A New Player in Town: Beef 'O' Brady's Lands in Tuscaloosa Listen up, sports fans and pub grub lovers of Tuscaloosa! Beef 'O' Brady's just kicked down the doors and expanded its reach, opening a location smack on McFarland Boulevard. The place threw open its doors on October 26 and is set to make waves in the local scene, driven by the dedicated hands of Mitul Patel and...

Continue Reading
Innovent's Big Leap: Targeting European Lung Cancer Market

Updated Category News Views 131

Innovent's Regulatory Milestone in Europe They say every underdog has its day, and for Innovent Biologics, that time just might be now. Receiving a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) is no small potatoes. Especially when we're talking lung cancer—a notorious heavyweight in the cancer world. The Finer Details of Zybrivo’s...

Continue Reading
Thunes Boosts Bhutan Remittances with Instant Payments

Updated Category News Views 161

Thunes' Network Expands to Bhutan: A Game Changer I'll say one thing clear—Thunes isn't messing around. They've just opened the gates for real-time payouts to Bhutan, and it's going to be a game-changer for those living abroad who want to send money back home. Look, for years, Non-Resident Bhutanese have been diving into hoops just to get their bucks across borders....

Continue Reading
Midea's R290 Tech: Real Green Cooling Revolution?

Updated Category News Views 0

A Fresh Breeze in Sustainable Cooling In the middle of Kigali’s innovation oasis, Midea RAC stood out at MOP38, the 38th Meeting of the Parties to the Montreal Protocol, flexing its sustainable tech muscles. We're talking about their R290 air conditioning technology—a natural refrigerant with zero ozone footprint and a global warming potential of a mere three. This is...

Continue Reading
CureGene's CG-0416: Promising Weight Loss Breakthrough

Updated Category News Views 0

Game-Changer in Weight Management? Oh, the obesity world is buzzing, folks! There's some big noise coming from CureGene, and it's catching the attention of every lab-coat smarty in town. They just tossed out some preclinical data on CG-0416 at Obesity Week 2026 that could shake up how we tackle weight loss. Anyone still clinging to their old diet books might want to take...

Continue Reading
Viking Ventures: Impacts of VK2735 on Obesity Examined

Updated Category News Views 277

Viking Therapeutics Reveal Surprising Data on VK2735 The latest from Viking Therapeutics' camp is giving obesity some serious food for thought, with new data making waves at the ObesityWeek® 2026 meeting. Their investigational dual agonist, VK2735, seems to be shaking things up, as early phase clinical data shows an impressive 74% of participants managed to improve at...

Continue Reading

Top 5 Most Recently Viewed Articles

Exciting Breakthroughs in Lung Cancer Treatment with Reqorsa

Updated Category News Views 182

Innovative Advances in Lung Cancer Treatment The fight against lung cancer continues to evolve, showcasing promising advancements that bring new hope to patients. Genprex, Inc. is at the forefront of this battle with its revolutionary gene therapy known as Reqorsa. This cutting-edge treatment has been developed specifically to target KRAS mutation in non-small cell lung...

Continue Reading
EfTEN United Property Fund Reports October Earnings and NAV

Updated Category News Views 192

Insights into EfTEN United Property Fund's Recent Performance EfTEN United Property Fund demonstrated a net profit of 110 thousand euros for October, totaling 2.214 million euros for the first ten months of the year, marking a significant improvement from 724 thousand euros during the same period last year. This impressive financial outcome led to a distribution to...

Continue Reading
Cardiff Oncology Reports Encouraging Results in mCRC Trial

Updated Category News Views 236

Cardiff Oncology Reveals Promising Clinical Trial Results Cardiff Oncology, Inc. (Nasdaq: CRDF), a pioneering clinical-stage biotechnology company, has recently announced encouraging results from its ongoing CRDF-004 clinical trial. This randomized Phase 2 trial is investigating the effects of onvansertib in patients suffering from first-line RAS-mutated metastatic...

Continue Reading
Japan's Growing Casting Polyurethane Market and Its Future

Updated Category News Views 127

Japan's Casting Polyurethane Market: A Rising Force The Japan casting polyurethane market is on the verge of significant transformation, anticipated to elevate from a valuation of US$ 134.74 million to a remarkable US$ 248.24 million by 2033. This growth trajectory highlights a compelling compound annual growth rate (CAGR) of 7.08%, revealing the underlying strength...

Continue Reading
Hudson Technologies Faces Challenges Amid Downgrade by B.Riley

Updated Category News Views 353

B.Riley Downgrades Hudson Technologies Stock In a recent market statement, B.Riley has lowered its outlook on Hudson Technologies (NASDAQ: HDSN), shifting the stock rating from Buy to Neutral. This adjustment comes amidst new growth projections adjusted downwards from +16.6% to +8.5%. The modification in expectations has been linked to ongoing pressures on...

Continue Reading